Infectious Disease

>

Latest News

Sen-Jam Pharmaceutical Reports Preliminary Phase 2 Results for SJP-002C in COVID-19 Treatment / Image credit: ©Mauro Rodrigues/AdobeStock
Sen-Jam Pharmaceutical Reports Preliminary Phase 2 Results for SJP-002C in COVID-19 Treatment

January 20th 2025

The novel therapeutic demonstrated a strong safety profile and showed efficacy in reducing symptoms during the early stages of treatment.

FDA Updates RSV Vaccine Labels to Include Guillain-Barré Syndrome Warning / Image credit: ©MargJohnsonVA/AdobeStock
FDA Updates RSV Vaccine Labels to Include Guillain-Barré Syndrome Warning

January 8th 2025

Bird Flu: First US Death Reported, NIH Updates Risk Assessment
Bird Flu: First US Death Reported, NIH Updates Risk Assessment

January 7th 2025

Sanofi and SK Bioscience Expand Pneumococcal Vaccine Partnership, Launch Phase 3 Trial for PCV21 / Image credit: ©Crystal Light/AdobeStock
Sanofi and SK Bioscience Expand Pneumococcal Vaccine Partnership, Launch Phase 3 Trial for PCV21

January 6th 2025

US Adults Lagging in Flu, COVID-19, and RSV Vaccination: Daily Dose / image credit: ©New Africa/AdobeStock
US Adults Lagging in Flu, COVID-19, and RSV Vaccination: Daily Dose

December 18th 2024

Latest CME Events & Activities

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

View More

<1
...
121122123124125
© 2025 MJH Life Sciences

All rights reserved.